“…In the dramatic scenario of intensive care bed scarcity, patients with cancer may need non-invasive options as a compromise (for example, radiotherapy, chemotherapy, or both) yet there may be treatment delays due to the pandemic. The potential disease progression, which is associated with quality of life and costs of care implications [14], has a knock-on effect that may happen with benign disorders too [15] Most health systems continue to focus on reactive care in hospitals -detecting and treating disease -and give too little attention to NCD prevention and control. They have yet to adapt their infrastructure to combine online, remote, and retail care settings to improve information, screening, treatment, and support for patients and caregivers.…”